RHB Retail Research
Trading Stocks - Sunzen Biotech
Sunzen Biotech may be in the process of extending its rebound after it recently crossed above the 21-day SMA line and holding above the MYR0.165 support level. A positive bias may emerge above this point with resistance levels marked at MYR0.19 and MYR0.215. A downside breach of MYR0.165 would invalidate this positive thesis.
Source: RHB Securities Research - 14 Sept 2020
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
19.60%More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
2
4
5
save malaysia!
Visa-free travel to China extended for Malaysians to 30 days
6
7
BFM Podcast
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
